Apr 23 |
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
|
Apr 11 |
Century buys a startup, raises funding in cell therapy expansion
|
Apr 11 |
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
|
Apr 8 |
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Mar 29 |
Century Therapeutics (NASDAQ:IPSC) Will Have To Spend Its Cash Wisely
|
Mar 25 |
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
|
Mar 20 |
Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
|
Mar 19 |
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
|
Mar 14 |
Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M
|
Mar 14 |
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
|